Issue Brief

Save Antibiotics - The Campaign Fact Sheet
Food Animal Production and Antibiotic Resistance

The Challenge Fact Sheet

Antibiotics are one of the most important tools in modern medicine. These drugs can mean the difference between life and death when humans contract a bacterial infection—from staph to salmonella to bacterial pneumonia. But overuse and misuse of these drugs are making bacteria more quickly resistant to essential antibiotics.

Antibiotic resistance complicates medical treatment, and frequently results in longer and more serious illness, and in some instances even death. According to a team of researchers affiliated with the Centers for Disease Control and Prevention (CDC), in 2002 alone, 99,000 people died in the U.S. of a hospital-acquired infectious disease.1 Children, the elderly and the chronically ill are particularly vulnerable to antibiotic-resistant infections. In 1998, the Institute of Medicine estimated that antibiotic resistance generated at least $4 billion to $5 billion per year in extra costs to the U.S. health care system. More recently, researchers with the Alliance for the Prudent Use of Antibiotics and Cook County Hospital in Chicago estimated that this number has grown to $16.6 billion to $26 billion per year. For these reasons, the CDC has declared that antibiotic resistance is among its top concerns.

The Solution

Working together, citizens, government, industry and public interest organizations have the tools to reduce overuse and misuse of antibiotics:

• Individuals can practice safe and effective use of antibiotics by only taking them when and as prescribed by a doctor.
• The food animal industry can adopt cost-effective alternative hygienic strategies for preventing illness in animals and discontinue use of antibiotics in feed for growth promotion.10

The Preservation of Antibiotics for Medical Treatment Act (PAMTA, H.R. 965) would withdraw the routine, not-therapeutic use of seven classes of antibiotics vitally important to human health from food animal production unless animals or herds are sick with diagnosed. Federal legislation such as this and/or regulation is needed in order to preserve the effectiveness of these life-saving drugs and to protect human health. 

Download the full PDF for more information 

Date added:
Mar 30, 2011

Related Resources

Top Food Companies Moving Away From Overuse of Antibiotics on Industrial Farms

Consumers across the United States are demanding meat and poultry raised without antibiotics—and large producers, restaurants, and other institutions are listening. Following is a list of some leading companies offering responsibly produced food.


FDA Reports that 25 of 26 Antibiotic Makers Will Comply with New Policies

On March 26, the U.S. Food and Drug Administration announced that 25 out of 26 drug companies that sell antibiotics for growth promotion “confirmed in writing their intent to engage with FDA as defined in Guidance #213.” FDA introduced this policy in final form Dec. 11, 2013, to curb antibiotic overuse and increase veterinary oversight on industrial farms. More

200,000+ Americans to FDA: Require Real Veterinary Oversight of Antibiotics on Industrial Farms

Three months ago, the U.S. Food and Drug Administration took an important step to protect people from superbugs. For the first time, it issued a set of proposed policies that would require food producers and feed mills to obtain a veterinarian’s order before adding antibiotics to animal feed or water. More

New FDA Policies on Antibiotics Use in Food Animal Production

Surveys of the animal production industry by the U.S. Department of Agriculture demonstrate that many farms and ranches administer antibiotics to healthy animals at low doses to offset overcrowding and poor sanitation and to accelerate livestock growth—practices that the medical and public health communities document as a significant factor in human antibiotic resistance. In 2013, FDA took steps to address these concerns.



MRSA, Football, and Industrial Farms

MRSA, or methicillin-resistant Staphylococcus aureus, is a type of bacteria that can infect a person’s skin, bones, lungs, heart, brain, and blood. Unlike common staph, MRSA does not respond to traditional antibiotics such as penicillin, making it more difficult and costlier to treat, and more lethal.